HEALTHSTORY 540· JULY 4, 2026

Protillion Biosciences Names Robert Hollingsworth Chief Scientific Officer

Protillion Biosciences has hired Robert Hollingsworth as its chief scientific officer, according to the STAT+ executive-tracking column "Up and Down the Ladder." Hollingsworth previously held the same title at Shoreline Therapeutics and…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 539Neugebauer Halts Fermi Proxy Campaign Despite 70% Shareholder Support After Judge's Last-Minute Recusal Derails Timeline NEXT STORY 541 →Elevance Health Sues U.S. Government for $115 Million Over Medicare Advantage Star Ratings

Keep reading

More from the desk.

16HEALTH

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

health2 MIN

32HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

34HEALTH

FDA Rejects ITM's Cancer Drug on Manufacturing Grounds, Blocking Novartis Rival

A manufacturing problem flagged by U.S. regulators has halted a radiopharmaceutical, a cancer therapy that works by delivering radioactive isotopes directly to tumor cells. The drug's maker, ITM Isotope Technologies Munich SE, had already…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk